Clinical Trials Directory

Trials / Conditions / Brain Tumor, Pediatric

Brain Tumor, Pediatric

21 registered clinical trials studyying Brain Tumor, Pediatric — 8 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingB7-H3.CD28Z.CART in CNS Neoplasms
NCT07390539
Robbie MajznerPhase 1
RecruitingIrradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention
NCT06599879
Institut Claudius RegaudN/A
RecruitingMethylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue
NCT06905587
Odense University HospitalPhase 3
RecruitingIntensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT)
NCT07338526
Tata Memorial CentreN/A
UnknownUtility of PET-MRI in Surveillance of Paediatric Brain Tumours
NCT05553899
Sheffield Children's NHS Foundation TrustN/A
RecruitingGD2-CAR T Cells for Pediatric Brain Tumours
NCT05298995
Bambino Gesù Hospital and Research InstitutePhase 1
Not Yet RecruitingRE-irradiation of Diffuse MIdline Glioma paTients
NCT06093165
Rigshospitalet, DenmarkN/A
TerminatedRRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant
NCT04525014
EpicentRx, Inc.Phase 1
RecruitingGenetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
NCT05672043
Beijing Tiantan Hospital—
CompletedMagrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors
NCT05169944
University of California, San FranciscoPhase 1
RecruitingEffectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
NCT06309251
Danone Nutricia SpA Società Benefit—
UnknownAcceptance and Commitment Therapy for Neuro-Oncology Wellbeing
NCT04722237
Nottingham University Hospitals NHS TrustN/A
UnknownNeurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients
NCT05709522
Aga Khan University—
CompletedClinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors
NCT04738162
Universität MünsterPhase 2
CompletedHRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Care
NCT04670016
University of Calgary—
CompletedStudy of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatr
NCT03936465
Dana-Farber Cancer InstitutePhase 1
CompletedEvaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescen
NCT04023669
St. Jude Children's Research HospitalPhase 1
CompletedPromotion of Well-being of Young Adult Brain Cancer Survivors
NCT03871686
University of Wisconsin, MadisonN/A
WithdrawnImmunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors
NCT04019470
Capital Medical University—
CompletedComponents of Social Functioning in Survivors of Pediatric Brain Tumors
NCT03361033
St. Jude Children's Research Hospital—
Active Not RecruitingSocial Emotional Development in Young Children With Cancer
NCT03086421
St. Jude Children's Research Hospital—